Phase II study of carboplatin and etoposide as salvage treatment for patients with metastatic breast cancer

Keyphrases

• Phase II Study 100%
• Salvage Treatment 100%
• Metastatic Breast Cancer 100%
• Etoposide 100%
• Carboplatin 100%
• Anemia 33%
• Median Survival 33%
• Treatment Response 33%
• Disease Progression 33%
• Liver 33%
• Thrombocytopenia 33%
• Fever 33%
• Lung 33%
• Leukopenia 33%
• Advanced Breast Cancer 33%
• Chemotherapeutic Treatment 33%
• Salvage Regimen 33%
• Stable Disease 33%
• Partial Response 33%
• Chest Wall 33%
• Infiltrating Breast Carcinoma 33%
• Pretreated Patients 33%
• Polytherapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Etoposide 100%
• Metastatic Breast Cancer 100%
• Carboplatin 100%
• Breast Cancer 33%
• Side Effect 33%
• Disease Exacerbation 33%
• Weakness 33%
• Breast Carcinoma 33%
• Disease 33%
• Anemia 33%
• Thrombocytopenia 33%
• Leukopenia 33%

Biochemistry, Genetics and Molecular Biology

• Thrombocytopenia 100%